Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does posaconazole prevent invasive fungal infections in patients with neutropenia?

Nature Clinical Practice Oncology volume 4, pages 512–513 (2007)Cite this article

boxed-textCornely OA et al. (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356: 348–359

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Groll AH et al. (2001) Prevention of fungal infections in children and adolescents with cancer [German]. Klin Padiatr 213 (Suppl 1): SA50–SA68

    Article  Google Scholar 

  2. Marr KA et al. (2004) Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 103: 1527–1533

    Article  CAS  Google Scholar 

  3. Slavin MA et al. (1995) Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation—a prospective, randomized, double-blind study. J Infect Dis 171: 1545–1552

    Article  CAS  Google Scholar 

  4. De Pauw BE and Donnelly JP (2007) Prophylaxis and aspergillosis—has the principle been proven? N Engl J Med 356: 409–411

    Article  CAS  Google Scholar 

  5. Ullmann AJ et al. (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356: 335–347

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Helen Jaques, Editorial Assistant, Nature Clinical Practice.

Author information

Author notes

  1. Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology, Children's University Hospital, Albert-Schweitzer-Strasse 33, 48129 Münster, Germany grollan@ukmuenster.de

Authors and Affiliations

  1. Head of the Infectious Disease Research Program and Attending Physician at the Center for Bone Marrow Transplantation and the Department of Hematology/Oncology at the University Children's Hospital, AH Groll is Associate Professor of Pediatrics, Münster, Germany.,

    Andreas H Groll

Authors
  1. Andreas H Groll
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author has declared associations with the following companies: research support from Gilead Sciences, Merck Sharpe & Dohme and Pfizer; and consultation and speaker fees from Astellas Pharma, Gilead Sciences, Merck Sharpe & Dohme, Pfizer, Schering-Plough and Unichem

Rights and permissions

Reprints and permissions

About this article

Cite this article

Groll, A. Does posaconazole prevent invasive fungal infections in patients with neutropenia?. Nat Rev Clin Oncol 4, 512–513 (2007). https://doi.org/10.1038/ncponc0907

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0907

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing